A human arterial transcriptomic signature predicts major adverse cardiac events and identifies novel, redox-related therapeutic targets within the vascular wall
Autors principals: | , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Idioma: | English |
Publicat: |
Oxford University Press
2021
|